0
0
2/9/23 at 10:07am
Organization
Labiotech.eu
Author
Jim Cornall
29 words
0
Comments
The first vaccine to potentially prevent Staphylococcal-induced toxic shock syndrome has successfully completed a phase 2 study.
You are the first to view
https://www.labiotech.eu/trends-news/first-toxic-shock-syndrome-vaccine-phase-2-study-completed/
Create an account
or login to join the discussion